Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Altria is mentioned multiple times so wondering if the "EIGHT BALL" is saying "IT IS LIKELY" for the deal to move forward.
Was this a video and do you have a link?
180 is a personal goal
Not liking that TWEET?????
I have been patient and keeping an open mind but I'm not happy with this TWEET. What CEO sends out "personal goals" that are company related???
180 is a personal goal
Kelly Whelan
@Kel928
Replying to
@Kevin14399724
180 is a personal goal. Go reread my statement. The company will release the PR at the appropriate time. I’m not going to be bullied into doing something not in the best interest of the Company just to satisfy a personal goal.
10:38 AM · Apr 7, 2020·Twitter for iPhone
More replies
Kevin
@Kevin14399724
·
1h
Replying to
@Kel928
Lol. Just a question. No bullying here.
HORUS
@inlightend1
·
2m
And u where do confident in your tweets. Now it’s a personal goal?
Bullying? There haven’t been any news since approval. I am a very long term investor like many others. We want some meat n potato’s.
Kelly tweet reply 20 hours ago
Covid is wreaking havoc with many things...we will have news out as soon as we are able. Fingers crossed for the 180. #doingeverythingwecan
Just need Trump to mention Lexaria!!!!
Maybe related to this????
Trump teases 'very exciting' FDA news
WOW, this should open some eyes into the Lexaria world of possibilities!!!
Circle K has a license to sell THC?
Hoping it's just panic selling thinking the Corona Virus is going to push it lower.
Added on January 2nd at $0.37
Here's yesterday's article from LinkedIn
CBDNewsBreaks – $LXX.CN $LXRP DehydraTECH(TM)-Enabled CBD Infused Powders Available for Sale Across the US
yuppppp. back to the .0008s......
Maybe with Mueller Sports Medicine????
Mueller Sports Medicine
This looks like a really good match for ActiPatch.....
#FDATODAY!!
We should easily be north of $1 already so.........
We should easily hit $1.00 today. No reason why this shouldn't happen.
That's where I found it as well. I assuming it's legit?
JANUARY 20, 2020 Investor Update
New Schedule for Investor Updates
The Company has decided to issue investor updates on a monthly basis, as part of efforts to continuously improve the breadth and quality of information provided to shareholders, as well as to prioritize the time of upper management in furthering the business interests of the Company. Any major events that occur between the monthly updates will be announced either via a press release or a special investor update.
The next investor update will be sent out on Monday, February 17th
FDA On-site Quality Audit
On Tuesday, January 14 the U.S. FDA conducted a quality systems audit at the Company’s manufacturing site in Frederick, Maryland. The two-day audit went smoothly, and no deviations/observations were identified in the Company’s quality management system. Additionally, the FDA provided several recommendations on how to continuously improve quality management and ensure global compliance, given that the Company’s products are exported to distributors in several continents such as MundiPharma SEA, and other potential distributors in Russia, South Africa and Ukraine with whom discussions are ongoing. Note that while the Company uses the distributor model internationally, an OEM-channel partner approach is being utilized within the United States.
The FDA periodically conducts on-site audits for registered medical device manufacturers to ensure that the manufacturing and distribution processes are compliant with federal regulations. The last FDA on-site audit for the Company took place in 2015.
Presentation at North American Neuromodulation Society (NANS) 2020 Conference
A research poster summarizing the outcome of the cervical osteoarthritis (COA) study (comparing ActiPatch® against COX-2 NSAID) was accepted for presentation at the NANS 2020 conference. Dr. Sree Koneru, VP Product Development, will present the poster on Friday, July 24 at a moderated session on non-invasive neuromodulation technologies.
NANS is a scientific organization dedicated to promoting and advancing neuromodulation as a treatment for various diseases, attracting key players in the neuromodulation industry. The COA poster summarizes the same data that was submitted to the FDA for the musculoskeletal pain 510(k) application, which is currently under review. As a note, the full research manuscript on the COA study has already been submitted to a major international medical journal and is currently being peer-reviewed for publication.
USA Channel Partners Update
There are three potential channel partners with whom the Company has signed non-disclosure agreements (NDAs):
• The first channel partner, who is dominant in the OTC footcare market, has indicated that a business proposal, for licensing the plantar fasciitis market, will be discussed at their board meeting on Thursday, January 23. The expectation has been set that discussions with BIEL towards finalizing a deal will take place following this meeting.
• The second channel partner, who is a key player in the global orthopedic appliances market, has indicated that a business proposal is being verified by their legal department. The expectation is that this proposal, spanning licensing for a multitude of musculoskeletal conditions, will be sent to BIEL in January, following which a deal will be finalized.
• The third channel partner, who is a key player in the global chronic wound management market, has requested that a teleconference, originally scheduled for Friday, January 17 be rescheduled to Friday, January 31. The expectation is to undertake discussions towards establishing a strategic alliance and introducing innovative electroceutical products to the market.
As indicated in prior updates, the Company’s sales strategy for 2020 will prioritize the OEM approach within the United States while strengthening the distributor model internationally- both with the intention of bringing ActiPatch/RecoveryRx to mass market. These partners will leverage their expertise in launching marketing campaigns and utilize a sales force that will promote the product to retail and clinical/hospital settings. With regards to the OEM model, tapping into existing sales channels that can capitalize on long term relationships and maximize growth is a winning strategy for BIEL - this strategy also helps the Company maintain a healthy product margin.
Cannadips CBD deal signed and Hill Street announcing "the next six to 12 months we hope to get the cannabis powder business up and running."
If this doesn't give us a decent bump in share price then........
You may have called this one. Halfway back to .40!
That would be amazing if it happens.
This was included in today's press release so the Altria deal most be still moving in a postive direction.
Additionally, Lexaria recently partnered with one of the world’s largest tobacco companies, which is providing up to $12 million to fund 100% of Lexaria’s portion of the obligations for clinical investigations and development of oral forms of nicotine delivery using the DehydraTECH™ drug delivery platform (cnw.fm/P7on4).
@keith_nalepka
2 hours ago
The real number of people with PF is much higher it appears. At least that’s what people have told me this week. I like our chances at providing relief. #footpain #OA #executing #OEM #greatteam
I agree, that's the best case scenario.
Wondering what happens if they do buy the division.
What's our payday if/when Altria buys the Nicotine division?
Do we get Altria shares??
Good news in they expand the licensing deal or they purchase one (Nicotine) or more of the divisions??
Do we BUY more, HOLD or SELL?????
If you had the money would you BUY now????
I'm ready to pull the trigger but.......
Just placed an order for ChrgD and a free sample of ViPova (Black) tea.
Looking forward to trying it out.
Use the Use promo code: freetea08 and support LEXARIA!